1. Home
  2. MTH vs STVN Comparison

MTH vs STVN Comparison

Compare MTH & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTH
  • STVN
  • Stock Information
  • Founded
  • MTH 1985
  • STVN 1949
  • Country
  • MTH United States
  • STVN Italy
  • Employees
  • MTH N/A
  • STVN N/A
  • Industry
  • MTH Homebuilding
  • STVN Containers/Packaging
  • Sector
  • MTH Consumer Discretionary
  • STVN Consumer Discretionary
  • Exchange
  • MTH Nasdaq
  • STVN Nasdaq
  • Market Cap
  • MTH 4.9B
  • STVN 5.7B
  • IPO Year
  • MTH 1988
  • STVN 2021
  • Fundamental
  • Price
  • MTH $68.63
  • STVN $23.25
  • Analyst Decision
  • MTH Buy
  • STVN Buy
  • Analyst Count
  • MTH 10
  • STVN 6
  • Target Price
  • MTH $74.42
  • STVN $25.08
  • AVG Volume (30 Days)
  • MTH 896.7K
  • STVN 303.9K
  • Earning Date
  • MTH 04-23-2025
  • STVN 05-08-2025
  • Dividend Yield
  • MTH 2.48%
  • STVN 0.25%
  • EPS Growth
  • MTH N/A
  • STVN N/A
  • EPS
  • MTH 9.89
  • STVN 0.50
  • Revenue
  • MTH $6,284,888,000.00
  • STVN $1,215,559,879.00
  • Revenue This Year
  • MTH $4.03
  • STVN $8.42
  • Revenue Next Year
  • MTH $9.15
  • STVN $10.36
  • P/E Ratio
  • MTH $7.02
  • STVN $43.94
  • Revenue Growth
  • MTH N/A
  • STVN 3.81
  • 52 Week Low
  • MTH $59.27
  • STVN $16.56
  • 52 Week High
  • MTH $106.99
  • STVN $28.77
  • Technical
  • Relative Strength Index (RSI)
  • MTH 52.61
  • STVN 61.06
  • Support Level
  • MTH $66.44
  • STVN $20.14
  • Resistance Level
  • MTH $70.29
  • STVN $24.00
  • Average True Range (ATR)
  • MTH 2.28
  • STVN 1.02
  • MACD
  • MTH 0.43
  • STVN 0.11
  • Stochastic Oscillator
  • MTH 63.01
  • STVN 71.00

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: